INNT
TOTAL INVALIDATION PROCESSED BY THE IB
26/07/2025
Voltar para busca
Dado oficial do USPTO
NEOHEME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
27/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
25/01/2017
Data de registro
23/01/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/08/2024
Última transação
27/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
27
Localização do titular
DE
Examinador
LAM, HAI-LY
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Siemens Healthcare GmbH
Representantes
Karla M. Weyand SIEMENS HEALTHCARE DIAGNOSTICS INC.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratorieschemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposesfor the detectionanalysis and treatment of cancer; cultures of microorganisms for medical and veterinary use
Classe 42
Scientific and technological servicesmedical testing in the fields of identificationanalysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identificationanalysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncologymolecular profilinggenomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software
Classe 44
Medical servicesin particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicineveterinary medicine and the diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical servicesmedical diagnostictheranosticprognostic and analytical servicesincluding molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/07/2025
INPC
INVALIDATION PROCESSED
09/07/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/04/2025
C71T
CANCELLED SECTION 71
09/08/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/01/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/09/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/05/2018
FIMP
FINAL DISPOSITION PROCESSED
02/05/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/04/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
23/01/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2017
PUBO
PUBLISHED FOR OPPOSITION
07/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/10/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
20/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
20/09/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/08/2017
ALIE
ASSIGNED TO LIE
28/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2017
RFNT
REFUSAL PROCESSED BY IB
04/08/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/07/2017
RFRR
REFUSAL PROCESSED BY MPU
17/07/2017
MAFR
APPLICATION FILING RECEIPT MAILED
15/07/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/07/2017
CNRT
NON-FINAL ACTION WRITTEN
13/07/2017
DOCK
ASSIGNED TO EXAMINER
11/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/07/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEOHEME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.